Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 2
2022 4
2023 7

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Assessing the utility of pepsinogens and gastrin-17 in gastric cancer detection.
Gašenko E, Bogdanova I, Sjomina O, Aleksandraviča I, Kiršners A, Ancāns G, Rudzīte D, Vangravs R, Sīviņš A, Škapars R, Tzivian L, Polaka I, Folkmanis V, Leja M. Gašenko E, et al. Among authors: vangravs r. Eur J Cancer Prev. 2023 Sep 1;32(5):478-484. doi: 10.1097/CEJ.0000000000000791. Epub 2023 Mar 13. Eur J Cancer Prev. 2023. PMID: 36912185
Who Could Be Blamed in the Case of Discrepant Histology and Serology Results for Helicobacter pylori Detection?
Skrebinska S, Megraud F, Daugule I, Santare D, Isajevs S, Liepniece-Karele I, Bogdanova I, Rudzite D, Vangravs R, Kikuste I, Vanags A, Tolmanis I, Savcenko S, Alix C, Herrero R, Park JY, Leja M. Skrebinska S, et al. Among authors: vangravs r. Diagnostics (Basel). 2022 Jan 6;12(1):133. doi: 10.3390/diagnostics12010133. Diagnostics (Basel). 2022. PMID: 35054298 Free PMC article.
Randomised clinical trial: comparison of efficacy and adverse effects of a standard triple clarithromycin-containing regimen with high-dose amoxicillin and bismuth therapy in Helicobacter pylori eradication.
Sjomina O, Lielause A, Rūdule A, Vangravs R, Paršutins S, Poļaka I, Daugule I, Stonāns I, Park JY, Leja M. Sjomina O, et al. Among authors: vangravs r. Eur J Cancer Prev. 2022 Jul 1;31(4):333-338. doi: 10.1097/CEJ.0000000000000718. Epub 2021 Dec 20. Eur J Cancer Prev. 2022. PMID: 35471812 Clinical Trial.
Factors Associated with False Negative Results in Serum Pepsinogen Testing for Precancerous Gastric Lesions in a European Population in the GISTAR Study.
Razuka-Ebela D, Polaka I, Daugule I, Parshutin S, Santare D, Ebela I, Rudzite D, Vangravs R, Herrero R, Young Park J, Leja M. Razuka-Ebela D, et al. Among authors: vangravs r. Diagnostics (Basel). 2022 May 7;12(5):1166. doi: 10.3390/diagnostics12051166. Diagnostics (Basel). 2022. PMID: 35626319 Free PMC article.
Prevalence and Potential Risk Factors of Helicobacter pylori Infection among Asymptomatic Individuals in Kazakhstan.
Mežmale L, Polaka I, Rudzite D, Vangravs R, Kikuste I, Parshutin S, Daugule I, Tazhedinov A, Belikhina T, Igissinov N, Park JY, Herrero R, Leja M. Mežmale L, et al. Among authors: vangravs r. Asian Pac J Cancer Prev. 2021 Feb 1;22(2):597-602. doi: 10.31557/APJCP.2021.22.2.597. Asian Pac J Cancer Prev. 2021. PMID: 33639679 Free PMC article.
Clarithromycin-containing triple therapy for Helicobacter pylori eradication is inducing increased long-term resistant bacteria communities in the gut.
Sjomina O, Vangravs R, Ļeonova E, Poļaka I, Pūpola D, Čivkulis K, Jeniceka A, Paršutins S, Stonāns I, Park JY, Engstrand L, Leja M. Sjomina O, et al. Among authors: vangravs r. Gut. 2023 Jun 26:gutjnl-2023-329792. doi: 10.1136/gutjnl-2023-329792. Online ahead of print. Gut. 2023. PMID: 37364984 No abstract available.
13 results